Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market

OAKLAND, N.J., June 28, 2022 /PRNewswire/ -- Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other bi...

June 28, 2022
12:00 PM

OAKLAND, N.J., June 28, 2022 /PRNewswire/ -- Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company ("Collagen Matrix" or "the Company"), announced today its 510(k) Clearance for a new Fibrillar Collagen Wound Dressing. Marking the 40th 510(k) in the Company's history, this approval represents a milestone for Collagen Matrix, Inc., as it now expands its product offerings into the advanced wound care market.

PRNewswire